The efficacy of sentinel lymph node mapping with indocyanine green in cervical cancer

Abstract Background Lymph node metastasis is a significant predictive factor for disease recurrence and survival in cervical cancer patients. Given the importance of lymph node metastasis, it is imperative that patients harboring metastasis are identified and can undergo appropriate treatment. Senti...

Full description

Bibliographic Details
Main Authors: Ju-Hyun Kim, Dae-Yeon Kim, Dae-Shik Suh, Jong-Hyeok Kim, Yong-Man Kim, Young-Tak Kim, Joo-Hyun Nam
Format: Article
Language:English
Published: BMC 2018-03-01
Series:World Journal of Surgical Oncology
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12957-018-1341-6
_version_ 1818265421510344704
author Ju-Hyun Kim
Dae-Yeon Kim
Dae-Shik Suh
Jong-Hyeok Kim
Yong-Man Kim
Young-Tak Kim
Joo-Hyun Nam
author_facet Ju-Hyun Kim
Dae-Yeon Kim
Dae-Shik Suh
Jong-Hyeok Kim
Yong-Man Kim
Young-Tak Kim
Joo-Hyun Nam
author_sort Ju-Hyun Kim
collection DOAJ
description Abstract Background Lymph node metastasis is a significant predictive factor for disease recurrence and survival in cervical cancer patients. Given the importance of lymph node metastasis, it is imperative that patients harboring metastasis are identified and can undergo appropriate treatment. Sentinel lymph node (SLN) mapping has drawn attention as a lymph node mapping technique. We evaluated the feasibility and efficacy of (SLN) mapping using indocyanine green (ICG) in cervical cancer. Methods We performed a single-center, retrospective study of 103 surgically treated cervical cancer patients who underwent SLN mapping. After using ICG to detect SLN during surgery, we removed the SLNs followed by laparoscopic or robotic-assisted radical surgery and bilateral pelvic lymphadenectomy. Results Stage IB1 was the most common (61.17%). At least one SLN was detected in all cases. Eighty-eight patients (85.44%) had bilateral pelvic SLNs. The mean number of SLN per patient was 2.34. The side-specific sensitivity was 71.43%, the specificity was 100%, the negative predictive value (NPV) was 93.98%, and the false negative rate (FNR) was 28.57%. In cases of tumors smaller than 2 cm with negative lymph node metastasis on imaging, the study revealed a side-specific sensitivity of 100%, a specificity of 100%, a NPV of 100%, and a FNR of 0%. Large tumor size (≥ 4 cm), a previous history of a loop electrosurgical excision procedure (LEEP), depth of invasion (≥ 50%), the microscopic parametrial (PM) invasion, and vaginal extension were significantly associated with the false-negative detection of SLN. Moreover, the microscopic PM invasion was the only risk factor of the false-negative detection of SLN in multivariate analysis. Conclusion SLN mapping with ICG in cervical cancer is feasible and has high detection rate. The sensitivity of 100% was high enough to perform SLN biopsy alone in an early stage in which the tumor is less than 2 cm, with no lymphadenopathy on image examination. However, for large or invasive tumors, we would have to be cautious about performing SLN biopsy alone. Trial registration Retrospectively registered 2017-0600.
first_indexed 2024-12-12T19:50:32Z
format Article
id doaj.art-6d4e2f038819454cb76cd9d74e13f223
institution Directory Open Access Journal
issn 1477-7819
language English
last_indexed 2024-12-12T19:50:32Z
publishDate 2018-03-01
publisher BMC
record_format Article
series World Journal of Surgical Oncology
spelling doaj.art-6d4e2f038819454cb76cd9d74e13f2232022-12-22T00:13:59ZengBMCWorld Journal of Surgical Oncology1477-78192018-03-011611710.1186/s12957-018-1341-6The efficacy of sentinel lymph node mapping with indocyanine green in cervical cancerJu-Hyun Kim0Dae-Yeon Kim1Dae-Shik Suh2Jong-Hyeok Kim3Yong-Man Kim4Young-Tak Kim5Joo-Hyun Nam6Department of Obstetrics and Gynecology, University of Ulsan College of MedicineDepartment of Obstetrics and Gynecology, University of Ulsan College of MedicineDepartment of Obstetrics and Gynecology, University of Ulsan College of MedicineDepartment of Obstetrics and Gynecology, University of Ulsan College of MedicineDepartment of Obstetrics and Gynecology, University of Ulsan College of MedicineDepartment of Obstetrics and Gynecology, University of Ulsan College of MedicineDepartment of Obstetrics and Gynecology, University of Ulsan College of MedicineAbstract Background Lymph node metastasis is a significant predictive factor for disease recurrence and survival in cervical cancer patients. Given the importance of lymph node metastasis, it is imperative that patients harboring metastasis are identified and can undergo appropriate treatment. Sentinel lymph node (SLN) mapping has drawn attention as a lymph node mapping technique. We evaluated the feasibility and efficacy of (SLN) mapping using indocyanine green (ICG) in cervical cancer. Methods We performed a single-center, retrospective study of 103 surgically treated cervical cancer patients who underwent SLN mapping. After using ICG to detect SLN during surgery, we removed the SLNs followed by laparoscopic or robotic-assisted radical surgery and bilateral pelvic lymphadenectomy. Results Stage IB1 was the most common (61.17%). At least one SLN was detected in all cases. Eighty-eight patients (85.44%) had bilateral pelvic SLNs. The mean number of SLN per patient was 2.34. The side-specific sensitivity was 71.43%, the specificity was 100%, the negative predictive value (NPV) was 93.98%, and the false negative rate (FNR) was 28.57%. In cases of tumors smaller than 2 cm with negative lymph node metastasis on imaging, the study revealed a side-specific sensitivity of 100%, a specificity of 100%, a NPV of 100%, and a FNR of 0%. Large tumor size (≥ 4 cm), a previous history of a loop electrosurgical excision procedure (LEEP), depth of invasion (≥ 50%), the microscopic parametrial (PM) invasion, and vaginal extension were significantly associated with the false-negative detection of SLN. Moreover, the microscopic PM invasion was the only risk factor of the false-negative detection of SLN in multivariate analysis. Conclusion SLN mapping with ICG in cervical cancer is feasible and has high detection rate. The sensitivity of 100% was high enough to perform SLN biopsy alone in an early stage in which the tumor is less than 2 cm, with no lymphadenopathy on image examination. However, for large or invasive tumors, we would have to be cautious about performing SLN biopsy alone. Trial registration Retrospectively registered 2017-0600.http://link.springer.com/article/10.1186/s12957-018-1341-6Sentinel lymph nodeIndocyanine greenSensitivity and specificityDetectionUterine cervical neoplasms
spellingShingle Ju-Hyun Kim
Dae-Yeon Kim
Dae-Shik Suh
Jong-Hyeok Kim
Yong-Man Kim
Young-Tak Kim
Joo-Hyun Nam
The efficacy of sentinel lymph node mapping with indocyanine green in cervical cancer
World Journal of Surgical Oncology
Sentinel lymph node
Indocyanine green
Sensitivity and specificity
Detection
Uterine cervical neoplasms
title The efficacy of sentinel lymph node mapping with indocyanine green in cervical cancer
title_full The efficacy of sentinel lymph node mapping with indocyanine green in cervical cancer
title_fullStr The efficacy of sentinel lymph node mapping with indocyanine green in cervical cancer
title_full_unstemmed The efficacy of sentinel lymph node mapping with indocyanine green in cervical cancer
title_short The efficacy of sentinel lymph node mapping with indocyanine green in cervical cancer
title_sort efficacy of sentinel lymph node mapping with indocyanine green in cervical cancer
topic Sentinel lymph node
Indocyanine green
Sensitivity and specificity
Detection
Uterine cervical neoplasms
url http://link.springer.com/article/10.1186/s12957-018-1341-6
work_keys_str_mv AT juhyunkim theefficacyofsentinellymphnodemappingwithindocyaninegreenincervicalcancer
AT daeyeonkim theefficacyofsentinellymphnodemappingwithindocyaninegreenincervicalcancer
AT daeshiksuh theefficacyofsentinellymphnodemappingwithindocyaninegreenincervicalcancer
AT jonghyeokkim theefficacyofsentinellymphnodemappingwithindocyaninegreenincervicalcancer
AT yongmankim theefficacyofsentinellymphnodemappingwithindocyaninegreenincervicalcancer
AT youngtakkim theefficacyofsentinellymphnodemappingwithindocyaninegreenincervicalcancer
AT joohyunnam theefficacyofsentinellymphnodemappingwithindocyaninegreenincervicalcancer
AT juhyunkim efficacyofsentinellymphnodemappingwithindocyaninegreenincervicalcancer
AT daeyeonkim efficacyofsentinellymphnodemappingwithindocyaninegreenincervicalcancer
AT daeshiksuh efficacyofsentinellymphnodemappingwithindocyaninegreenincervicalcancer
AT jonghyeokkim efficacyofsentinellymphnodemappingwithindocyaninegreenincervicalcancer
AT yongmankim efficacyofsentinellymphnodemappingwithindocyaninegreenincervicalcancer
AT youngtakkim efficacyofsentinellymphnodemappingwithindocyaninegreenincervicalcancer
AT joohyunnam efficacyofsentinellymphnodemappingwithindocyaninegreenincervicalcancer